Skip to main content
. 2020 Jan 9;12(1):158. doi: 10.3390/cancers12010158

Table 5.

Prognostic factors: univariate and multivariate analyses (R0 cases).

Prognostic Variables No. Median OS Univariate p-Value Multivariate p-Value Odds Ratio
(±CI 95%)
Lymphadenectomy
D1 8 7.3 (5.2–9.3) 0.001 0.014 0.4 (0.2–0.8)
D2 58 16.0 (9.8–22.1)
D > 2 51 14.0 (6.2–21.7)
pT
1–2 7 38.0 (20.0–82.0) 0.006 0.042 9.4 (1.1–81.6)
3 40 11.2 (5.0–17.4)
4a 56 18.7 (9.7–27.6)
4b 14 5.0 (1.7–8.3)
pN
0 14 38.0 (26.5–49.5) 0.001 0.016 3.0 (1.3–7.1)
1 10 82.4 (25.0–85.0)
2 21 21.4 (14.5–28.2)
3a 36 11.0 (6.1–15.9)
3b 32 15.0 (9.5–20.5)
x 4 6.0 (4.1–7.9)
Number of resected nodes
<16 5 6.0 (1.8–10.1) 0.034 n.s.
16–22 17 5.0 (0.1–18.5)
23–29 25 15.3 (9.3–21.3)
30–44 36 18.4 (8.0–28.8)
45–59 26 14.0 (2.7–25.2)
60–74 6 21.4 (0.2–53.0)
>74 2 1.3
Hystology
Intestinal 49 13.5 (5.9–21.0) 0.011 n.s.
Diffuse 52 16.0 (10.7–21.2)
Mixed 11 7.3 (0.8–13.7)
Other 5 15.3 (0.1–33.7)
Chemotherapy
Yes 77 17.0 (9.8–24.2) 0.040 n.s.
No 40 11.0 (3.8–18.1)